Jeff Yass’s Kailera Therapeutics KLRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$259K Sell
22,688
-9,921
-30% -$168K ﹤0.01% 11305
2026
Q2
$718K Buy
+32,609
New +$717K ﹤0.01% 9041

Other funds holding KLRA

Jeff Yass's KLRA Position: Q3 2026 in Review

Jeff Yass reduced its Kailera Therapeutics (KLRA) stake by 30% in Q3 2026, selling an estimated $168K and leaving 22,688 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #11305.

Jeff Yass first reported a position in KLRA in Q2 2026 and has held it in 2 quarters since. The position peaked at $718K in Q2 2026. 129 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • Jeff Yass held 22,688 shares of Kailera Therapeutics worth $259K as of Q3 2026.
  • Jeff Yass sold 9,921 Kailera Therapeutics shares in Q3 2026, an estimated $168K.
  • Kailera Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11305 holding.
  • Jeff Yass first reported a position in Kailera Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Jeff Yass's Kailera Therapeutics position peaked at $718K in Q2 2026.
  • 129 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.